CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $34 | $16 | $30 | $41 |
| - Cash | $9 | $12 | $11 | $12 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $29 | $7 | $22 | $32 |
| Revenue | $0 | $0 | $2 | $0 |
| % Growth | -57% | -91.3% | 1,153% | – |
| Gross Profit | -$0 | -$0 | $2 | -$0 |
| % Margin | -539% | -131.8% | 79% | -213.4% |
| EBITDA | -$3 | -$3 | -$1 | -$4 |
| % Margin | -4,233.8% | -1,647.5% | -58.8% | -2,217.1% |
| Net Income | -$3 | -$3 | -$1 | -$4 |
| % Margin | -4,523.4% | -1,869.8% | -70.7% | -2,364.6% |
| EPS Diluted | -0.27 | -0.28 | -0.13 | -0.34 |
| % Growth | 3.6% | -115.4% | 61.8% | – |
| Operating Cash Flow | -$3 | -$2 | -$1 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$3 | -$2 | -$1 | -$4 |